Loading page content…
Loading page content…
| Source: | Find a Tender Service (FTS) |
| Notice Type: | Award notice |
| Buyer: | The Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority") |
| Main Category: | Goods |
| Procurement Method: | Open procedure |
| Tender Status: | Complete |
| Estimated Value (ex. VAT): | Not specified |
| Release Date: | 21 April 2023 |
| Application Deadline: | — |
| Procurement ID (OCID): | ocds-h6vhtk-0368ee |
| Notice Reference: | 011419-2023 |
All 2 notices for this procurement, oldest first.
Generic and Biosimilar Cancer Medicines
Earlier notices predate the Procurement Act 2023 (commenced 24 Feb 2025) and therefore don't carry UK1–UK17 codes.
This Framework Agreement is for the supply of generic and biosimilar cancer medicines to NHS Scotland. The Goods were separated into forty-one (41) categories, each of which is identified as a “Lot”. Full details of each awarded Lot is contained in section II.2 of this Notice.
Published contracts in the last 12 months
3
total contracts
£53.0m
total value
£52,999,636
average contract size
Typical categories
Pipeline status
Not addedContract imported automatically · AI writes the response
Need help writing this bid?
Our specialists write winning tender responses. Free consultation, no obligation.
Book a free consultation →